INOVOLINE
Phase NA Completed
101 enrolled
Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Completed
83 enrolled 21 charts
Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy
Phase 2 Completed
113 enrolled 18 charts
A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1/2 Completed
87 enrolled 22 charts
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
145 enrolled 47 charts
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Phase 1/2 Completed
229 enrolled
LARENA
Completed
351 enrolled
Study of AK112 in the Treatment of Advanced Gynecological Tumors
Phase 2 Completed
53 enrolled
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Phase 1 Completed
48 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
Study of Continuous OSI-906 Dosing
Phase 1 Completed
95 enrolled
Study of Intermittent OSI-906 Dosing
Phase 1 Completed
79 enrolled
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled
Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
Phase NA Completed
22 enrolled 6 charts
EDO-S101
Phase 1/2 Completed
71 enrolled 39 charts
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer
Phase 1 Completed
52 enrolled 21 charts
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase 2 Completed
78 enrolled 11 charts
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.
Phase 1 Completed
29 enrolled
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1/2 Completed
109 enrolled 25 charts
Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
Phase 1/2 Completed
40 enrolled
Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer
Phase 2 Completed
52 enrolled
ENDOPIK
Phase 2 Completed
24 enrolled
ENDOVIE
Completed
200 enrolled
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
Phase 2 Completed
275 enrolled 13 charts
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Phase 2 Completed
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
Phase 1 Completed
11 enrolled
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
Phase 1 Completed
13 enrolled 10 charts
CABOCOL-01
Phase 2 Completed
57 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Phase 2 Completed
30 enrolled 15 charts
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
Phase 2 Completed
40 enrolled
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Phase 1 Completed
174 enrolled 68 charts
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Phase 1 Completed
138 enrolled 98 charts
RECHARGE
Phase NA Completed
10 enrolled
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Phase 1 Completed
22 enrolled
Meta-Four
Phase NA Completed
101 enrolled
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Phase 1 Completed
32 enrolled
GCC0319
Phase 1/2 Completed
38 enrolled 9 charts
HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry
Completed
193 enrolled
AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Phase 1 Completed
103 enrolled
MicroPCI
Phase NA Completed
30 enrolled
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Phase 2 Completed
15 enrolled 12 charts
CT Antigen TCR-redirected T Cells for Ovarian Cancer.
Phase 1/2 Completed
9 enrolled 12 charts
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Phase 2 Completed
14 enrolled
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
Phase 2 Completed
201 enrolled 23 charts
NGR018
Phase 2 Completed
119 enrolled
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Phase 1/2 Completed
12 enrolled 19 charts
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
Phase 1 Completed
24 enrolled
Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer
Completed
109 enrolled